Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Cancer Chemother Pharmacol

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    February 2019
  1. NAUSHAD SM, Dorababu P, Rupasree Y, Pavani A, et al
    Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2019 Feb 26. pii: 10.1007/s00280-019-03803.
    PubMed     Text format     Abstract available


    January 2019
  2. YOUSEF AM, Farhad R, Alshamaseen D, Alsheikh A, et al
    Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2019 Jan 25. pii: 10.1007/s00280-019-03776.
    PubMed     Text format     Abstract available


    November 2018
  3. FOSTER JH, Thompson PA, Bernhardt MB, Margolin JF, et al
    A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.
    Cancer Chemother Pharmacol. 2018 Nov 28. pii: 10.1007/s00280-018-3733.
    PubMed     Text format     Abstract available


  4. KHERA S, Trehan A, Bhatia P, Singh M, et al
    Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2018 Nov 24. pii: 10.1007/s00280-018-3732.
    PubMed     Text format     Abstract available


    October 2018
  5. NERSTING J, Nielsen SN, Grell K, Paerregaard M, et al
    Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy.
    Cancer Chemother Pharmacol. 2018 Oct 15. pii: 10.1007/s00280-018-3704.
    PubMed     Text format     Abstract available


    May 2018
  6. GAO C, Hu S, Guo M, Hai X, et al
    Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.
    Cancer Chemother Pharmacol. 2018 May 29. pii: 10.1007/s00280-018-3606.
    PubMed     Text format     Abstract available


    March 2018
  7. RIVERA-DEL VALLE N, Cheng T, Irwin ME, Donnella H, et al
    Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
    Cancer Chemother Pharmacol. 2018;81:483-495.
    PubMed     Text format     Abstract available


  8. BLOTNER S, Chen LC, Ferlini C, Zhi J, et al
    Phase 1 summary of plasma concentration-QTc analysis for idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors and AML.
    Cancer Chemother Pharmacol. 2018;81:597-607.
    PubMed     Text format     Abstract available


  9. GERBEK T, Ebbesen M, Nersting J, Frandsen TL, et al
    Role of TPMT and ITPA variants in mercaptopurine disposition.
    Cancer Chemother Pharmacol. 2018;81:579-586.
    PubMed     Text format     Abstract available


    February 2018
  10. SCHOCH LK, Asiama A, Zahurak M, Shanbhag S, et al
    Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients.
    Cancer Chemother Pharmacol. 2018;81:347-354.
    PubMed     Text format     Abstract available


    January 2018
  11. KIM SY, Park JH, Yoon SY, Cho YH, et al
    A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2018 Jan 2. pii: 10.1007/s00280-017-3514.
    PubMed     Text format     Abstract available


  12. NIKANJAM M, Capparelli EV, Lancet JE, Louie A, et al
    Persistent cytarabine and daunorubicin exposure after administration of novel liposomal formulation CPX-351: population pharmacokinetic assessment.
    Cancer Chemother Pharmacol. 2018;81:171-178.
    PubMed     Text format     Abstract available


    December 2017
  13. VOLLER S, Pichlmeier U, Zens A, Hempel G, et al
    Pharmacokinetics of recombinant asparaginase in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 Dec 5. pii: 10.1007/s00280-017-3492.
    PubMed     Text format     Abstract available


    November 2017
  14. EMADI A, Law JY, Strovel ET, Lapidus RG, et al
    Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Nov 8. doi: 10.1007/s00280-017-3459.
    PubMed     Text format     Abstract available


    October 2017
  15. MCATEE CL, Schneller N, Brackett J, Bernhardt MB, et al
    Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification.
    Cancer Chemother Pharmacol. 2017 Oct 19. doi: 10.1007/s00280-017-3453.
    PubMed     Text format     Abstract available


    August 2017
  16. BEN HASSINE I, Gharbi H, Soltani I, Ben Hadj Othman H, et al
    Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Aug 23. doi: 10.1007/s00280-017-3424.
    PubMed     Text format     Abstract available


    June 2017
  17. DEHGHAN-NAYERI N, Eshghi P, Pour KG, Rezaei-Tavirani M, et al
    Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 Jun 5. doi: 10.1007/s00280-017-3347.
    PubMed     Text format     Abstract available


    May 2017
  18. MESRIAN TANHA H, Rahgozar S, Mojtabavi Naeini M
    ABCC4 functional SNP in the 3' splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 May 26. doi: 10.1007/s00280-017-3340.
    PubMed     Text format     Abstract available


    March 2017
  19. LANVERS-KAMINSKY C
    Asparaginase pharmacology: challenges still to be faced.
    Cancer Chemother Pharmacol. 2017;79:439-450.
    PubMed     Text format     Abstract available


  20. YE YE, Woodward CN, Narasimhan NI
    Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans.
    Cancer Chemother Pharmacol. 2017;79:507-518.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: